Mical C. Paul
Advanced in Staphylococcal Meningitis

Mical C. Paul

Efron St 1, 
Haifa, HA, IL 
Advanced in Staphylococcal Meningitis
Efron St 1, 
Haifa, HA, IL 
OverviewLocationsClinical Research

Overview

Mical Paul practices in Haifa, Israel. Ms. Paul is rated as an Advanced expert by MediFind in the treatment of Staphylococcal Meningitis. Her top areas of expertise are Sepsis, Agranulocytosis, Staphylococcal Meningitis, Kidney Transplant, and Bone Marrow Transplant.

Her clinical research consists of co-authoring 407 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Staphylococcal Meningitis.

Gender
Female

Locations

Efron St 1, Haifa, HA 31096, Israel
Other Locations
8th Haalia Hashnia St, Haifa, HA 31096, Israel
HaAliya HaShniya St 8, Haifa, HA, Israel
6 Ha'Aliya Street, 31096, Haifa, HA, Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Optimal Antibiotic Treatment of Moderate to Severe Bacterial Infections: Integration of PCR Technology and Medical Informatics/Artificial Intelligence
Optimal Antibiotic Treatment of Moderate to Severe Bacterial Infections: Integration of PCR Technology and Medical Informatics/Artificial Intelligence
Enrollment Status: Completed
Publish Date: April 09, 2024
Intervention Type: Other
Study Phase: Not Applicable
Duration of Antibiotics for the Treatment of Gram-negative Bacilli Bacteremia - a Randomized Controlled Trial
Duration of Antibiotics for the Treatment of Gram-negative Bacilli Bacteremia - a Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: April 09, 2019
Intervention Type: Drug
Study Phase: Not Applicable
CAMERA 2 - Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus Infection - An Investigator-initiated, Multi-centre, Parallel Group, Open Labelled Randomised Controlled Trial
CAMERA 2 - Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus Infection - An Investigator-initiated, Multi-centre, Parallel Group, Open Labelled Randomised Controlled Trial
Enrollment Status: Terminated
Publish Date: December 19, 2018
Intervention Type: Drug
Study Phase: Phase 3
Multicenter Open-label RCT to Compare Colistin Alone vs. Colistin Plus Meropenem
Multicenter Open-label RCT to Compare Colistin Alone vs. Colistin Plus Meropenem
Enrollment Status: Completed
Publish Date: April 12, 2017
Intervention Type: Drug
Study Phase: Phase 4
View 3 Less Clinical Trials

407 Total Publications

Virulence factors are preserved within carbapenem-resistant Acinetobacter baumannii clades.
Virulence factors are preserved within carbapenem-resistant Acinetobacter baumannii clades.
Journal: Virulence
Published: August 24, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Paul's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 40 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile